EUVIMEDEUVIMED entdecken
Open Access

Voxelotor does not inhibit sickle hemoglobin fiber formation upon complete deoxygenation

Eli H Worth, Mark K Fugate, Frank A Ferrone

Biophysical Journal · 2023

DOI: 10.1016/j.bpj.2023.05.034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biophysical Journal, 2023. Verfasst von Eli H Worth und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physics, Drexel University, Philadelphia, Pennsylvania. Hauptthemen laut MEDLINE: Hemoglobin, Sickle, Anemia, Sickle Cell. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The drug voxelotor (commercially known as Oxbryta) has been approved by the US Food and Drug Administration for the treatment of sickle cell disease. It is known to reduce disease-causing sickling by inhibiting the transformation of the non-polymerizing, high-oxygen-affinity R quaternary structure of sickle hemoglobin into its polymerizing, low-affinity T quaternary structure. It has not been established whether the binding of the drug has anti-sickling effects beyond restricting the change of quaternary structure. By using a laser photolysis method that employs microscope optics, we have determined that fully deoxygenated sickle hemoglobin will assume the T structure. We show that the nucleation rates essential to generate the sickle fibers are not significantly affected by voxelotor. The method employed here should be useful for determining the mechanism of sickling inhibition for proposed drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemoglobin, SickleAnemia, Sickle CellHumansOxygenBenzaldehydesPyrazinesPyrazoles

Substanzen

Hemoglobin, SickleOxygenBenzaldehydesvoxelotorPyrazinesPyrazoles

Autor:innen und Institutionen

  • Department of Physics, Drexel University, Philadelphia, Pennsylvania.
  • Department of Physics, Drexel University, Philadelphia, Pennsylvania. Electronic address: ferronfa@drexel.edu.

Zitieren

APA

Worth, E. H., Fugate, M. K., & Ferrone, F. A. (2023). Voxelotor does not inhibit sickle hemoglobin fiber formation upon complete deoxygenation. Biophysical Journal. https://doi.org/10.1016/j.bpj.2023.05.034

Vancouver

Worth EH, Fugate MK, Ferrone FA. Voxelotor does not inhibit sickle hemoglobin fiber formation upon complete deoxygenation. Biophysical Journal. 2023. doi:10.1016/j.bpj.2023.05.034

BibTeX
@article{Worth2023,
  author = {Worth, Eli H and Fugate, Mark K and Ferrone, Frank A},
  title = {Voxelotor does not inhibit sickle hemoglobin fiber formation upon complete deoxygenation},
  journal = {Biophysical Journal},
  year = {2023},
  doi = {10.1016/j.bpj.2023.05.034}
}
Kostenlos starten →